Donor site morbidity after microvascular medial femoral condylar flap procurement for facial reconstruction

Int J Oral Maxillofac Surg. 2020 May;49(5):569-575. doi: 10.1016/j.ijom.2019.11.006. Epub 2019 Dec 6.

Abstract

The medial femoral condyle (MFC) flap is considered an ideal graft for bone reconstructions. This study was performed to evaluate donor site knee joint function and scar appearance after MFC flap procurement. Adult patients who had undergone facial reconstruction with an MFC flap between March 2011 and March 2017 at the University Hospital Salzburg were enrolled. Knee function was assessed postoperatively using two validated orthopaedic scores: Tegner Lysholm Knee Scoring Scale (TL) and Knee Society Score (KSS); both range from 0 to 100 (100 being no impairment). Scars were evaluated using the Patient and Observer Scar Assessment Scale (POSAS) (range 6-60). Thirty-eight patients were enrolled. The average postoperative TL score was 95.68 (range 66-100). The mean KSS clinical examination and function scores were 96.8 (range 58-100) and 97.11 (range 60-100), respectively. Flap type (osteocutaneous vs. non-osteocutaneous) did not correlate with TL or KSS scores. KSS and TL scores showed no association with vascular pedicle length or transplant volume. The average POSAS patient and observer scores were 6.84 and 15.24, respectively. POSAS observer scores were significantly higher for osteocutaneous flaps than for non-osteocutaneous flaps. The MFC flap causes minimal donor site morbidity. No knee joint instability or range of motion limitation was found. Postoperative TL and KSS scores indicated excellent knee function.

Keywords: cosmetics; donor site morbidity; femur; functional results; head and neck reconstruction; medial femoral condylar flap; microvascular bone graft.

MeSH terms

  • Adult
  • Femur
  • Humans
  • Knee Joint
  • Plastic Surgery Procedures*
  • Retrospective Studies
  • Surgical Flaps*